Introduction: The Promise and Challenge of Spatial Metabolomics

Metabolomics provides a powerful lens for understanding cellular processes, but most conventional methods miss one critical dimension: spatial context. Bulk metabolomics erases tissue-level architecture, while single-cell techniques preserve detail but lose structural integrity. For researchers in oncology and metabolic disease, this means that spatial signatures - the “where” of metabolism are often lost.

Spatial metabolomics bridges this gap by mapping metabolites directly onto tissue structure, enabling the discovery of spatially resolved biomarkers that can inform drug discovery and translational research. Yet, scaling these workflows is far from straightforward. Handling multi-isotope labeling (e.g., ¹³C, ¹⁵N), ensuring rigorous quality control, and automating LC-MS analysis remain major hurdles. Without integrated solutions, scientists are left stitching together fragmented tools and facing weeks of delays in generating actionable outputs.

A precision medicine startup focused on spatial biomarker discovery for oncology and metabolic disease research encountered these very challenges.

The Impact: High-Quality Outputs in Hours, Not Weeks

With Elucidata’s Polly platform, the team reimagined its spatial metabolomics pipeline. More than 100 samples were processed at scale, supporting multi-isotope labeling with natural abundance correction. Workflows that previously took weeks now delivered actionable results in hours, enabling real-time insight generation for metabolic flux analysis.

Key outcomes included:

• 6X faster spatial metabolomics workflow
• 90% reduction in QC-related reruns
• Automated integration of spatial and isotopic data for reliable downstream insights

As their Senior Scientist in Spatial Biology explained:

“Our workflows couldn’t handle the complexity of labeled spatial metabolomics at scale. Elucidata’s platform gave us high-quality data outputs within hours, not weeks—while preserving critical spatial and isotopic context.”

The Challenge: Bottlenecks in Traditional Metabolomics Workflows

The startup’s research ambitions were constrained by conventional metabolomics tools. Bulk methods obscured spatial variation, while single-cell techniques disrupted tissue architecture. Manual LC-MS analysis for isotope-labeled samples was slow, prone to reruns, and lacked built-in support for natural abundance correction or outlier detection. On top of that, fragmented workflows required multiple platforms for what should have been a single, streamlined analysis.

These bottlenecks delayed translational insights and slowed the path from discovery to therapeutic development.

The Solution: A Harmonized Spatial Metabolomics Pipeline with Polly

Elucidata deployed its integrated LC-MS data solution on Polly to deliver a harmonized, scalable workflow. The pipeline included:

• Processing of 100+ spatial metabolomics samples with multi-isotope support (¹³C, ¹⁵N)
• Automated spatial segmentation, peak picking, and QC with manual override flexibility
• Natural abundance correction and delivery of fractional enrichment outputs
• Cohort-based comparative visualizations in real time, enabling side-by-side condition analysis

By orchestrating these steps in a single platform, Polly eliminated fragmentation and gave the team reproducible, high-quality outputs ready for downstream analysis.

Why Scalable Spatial Metabolomics Matters

As precision medicine moves forward, understanding not just what metabolites are present but where they are localized is becoming essential. Spatial metabolomics enables researchers to connect biochemical flux with tissue structure, uncovering spatially resolved biomarkers that bulk or single-cell approaches alone cannot capture.

By standardizing and automating complex LC-MS workflows, Elucidata helps teams accelerate spatial metabolomics, reduce reruns, and generate AI-ready datasets that drive translational insights in oncology and metabolic disease research.

Looking to scale your spatial metabolomics workflows? Talk to our team about integrating multi-isotope analysis, QC automation, and real-time cohort insights.

References

1. Alexandrov T, et al. Spatial metabolomics and imaging mass spectrometry in the age of artificial intelligence. Annu Rev Biomed Data Sci. 2020;3:61–87.
2. Rappez L, et al. SpaceM reveals metabolic states of single cells. Nat Methods. 2021;18(7):799–805.
3. Vermeulen M, Hanahan D. Metabolic signatures in cancer: from pathways to biomarkers. Nat Rev Cancer. 2021;21(12):786–805.

‍